Difference between revisions of "ALK inhibitors"
Jump to navigation
Jump to search
Line 10: | Line 10: | ||
*[[Inflammatory myofibroblastic tumour]]. | *[[Inflammatory myofibroblastic tumour]]. | ||
*[[ALK positive lung cancer]]. | *[[ALK positive lung cancer]]. | ||
*[[ALK translocation renal cell carcinoma]]. | |||
==References== | ==References== |